Research & Faculty
Bone and tissue regrowth is a way for patients to experience complete recovery from previously debilitating conditions such as arthritis, cancer, osteoporosis and bone fractures. The Musculoskeletal Biology Research Group at NEOMED is focused on developing these re-growth processes to address the needs of our aging population.
Areas of Study
Osteoporosis is identified by low bone mass and increased bone fragility. This metabolic bone disease afflicts nearly 53 million Americans in 2010. The projected growth in by 2020 will be 61 million Americans. Osteoarthritis is a type of arthritis where the flexible tissue at the end of bones wears down. Researchers discovered a new gene protein called Osteoactivin. The technology is patented protected and helps bone to grow/regenerate.
Skeletal trauma (or fractures) accounts for more than 1.5 million fractures a year
Researchers study tumor growth, metastasis into bone, and drug delivery options.
Researchers look at the evolution, biomechanics, and molecular approaches to diseases processes.
Questions? Please contact:
Fayez Safadi, Ph.D.
Director of Musculoskeletal Biology Focus Area